Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03KLN
|
||||
| Former ID |
DNC005727
|
||||
| Drug Name |
1-(3-Methoxy-naphthalen-2-yl)-1H-imidazole
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527801] | ||
| Formula |
C14H12N2O
|
||||
| Canonical SMILES |
COC1=CC2=CC=CC=C2C=C1N3C=CN=C3
|
||||
| InChI |
1S/C14H12N2O/c1-17-14-9-12-5-3-2-4-11(12)8-13(14)16-7-6-15-10-16/h2-10H,1H3
|
||||
| InChIKey |
HDJQGQGNKJFUSV-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [527801] | |
| Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527801] | ||
| NetPath Pathway | FSH Signaling Pathway | ||||
| PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
| PathWhiz Pathway | Androgen and Estrogen MetabolismPW000141:Steroidogenesis | ||||
| WikiPathways | Metapathway biotransformation | ||||
| Tryptophan metabolism | |||||
| Oxidation by Cytochrome P450 | |||||
| Ovarian Infertility Genes | |||||
| Metabolism of steroid hormones and vitamin D | |||||
| FSH signaling pathway | |||||
| Integrated Breast Cancer Pathway | |||||
| Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
| Corticotropin-releasing hormone | |||||
| References | |||||